Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Green

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
British Journal of Pharmacology|August 18, 2009
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?David J Grieve, Roslyn S Cassidy, Brian D Green
Expert Opinion on Investigational Drugs|July 16, 2010
Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazoneClifford J Bailey, Brian D Green, Peter R Flatt
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetesPeter R Flatt, Clifford J Bailey, Brian D Green
Diabetes & Vascular Disease Research|December 13, 2006
Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetesBrian D Green, Peter R Flatt, Clifford J Bailey
Expert Opinion on Emerging Drugs|August 31, 2006
Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetesBrian D Green, Peter R Flatt, Clifford J Bailey
European Journal of Pharmacology|November 18, 2009
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxalineNigel Irwin, Peter R Flatt, Steven Patterson, et al.
Food Chemistry|July 21, 2015
Whey proteins have beneficial effects on intestinal enteroendocrine cells stimulating cell growth and increasing the production and secretion of incretin hormonesAnna L Gillespie, Danielle Calderwood, Laura Hobson, et al.
Nutrition Bulletin|August 31, 2022
Can sprouting reduce phytate and improve the nutritional composition and nutrient bioaccessibility in cereals and legumes?Hannah Elliott, Patrick Woods, Brian D Green, et al.
Frontiers in Pharmacology|December 14, 2018
A Multi-Mode Bioactive Agent Isolated From <i>Ficus microcarpa</i> L. Fill. With Therapeutic Potential for Type 2 Diabetes MellitusNosheen Akhtar, Laila Jafri, Brian D Green, et al.
Frontiers in Pharmacology|July 2, 2019
Corrigendum: A Multi-Mode Bioactive Agent Isolated From <i>Ficus microcarpa</i> L. Fill. With Therapeutic Potential for Type 2 Diabetes MellitusNosheen Akhtar, Laila Jafri, Brian D Green, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Pharmacology|August 18, 2009
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?David J Grieve, Roslyn S Cassidy, Brian D Green
Expert Opinion on Investigational Drugs|July 16, 2010
Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazoneClifford J Bailey, Brian D Green, Peter R Flatt
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetesPeter R Flatt, Clifford J Bailey, Brian D Green
Diabetes & Vascular Disease Research|December 13, 2006
Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetesBrian D Green, Peter R Flatt, Clifford J Bailey
Expert Opinion on Emerging Drugs|August 31, 2006
Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetesBrian D Green, Peter R Flatt, Clifford J Bailey
European Journal of Pharmacology|November 18, 2009
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxalineNigel Irwin, Peter R Flatt, Steven Patterson, et al.
Food Chemistry|July 21, 2015
Whey proteins have beneficial effects on intestinal enteroendocrine cells stimulating cell growth and increasing the production and secretion of incretin hormonesAnna L Gillespie, Danielle Calderwood, Laura Hobson, et al.
Nutrition Bulletin|August 31, 2022
Can sprouting reduce phytate and improve the nutritional composition and nutrient bioaccessibility in cereals and legumes?Hannah Elliott, Patrick Woods, Brian D Green, et al.
Frontiers in Pharmacology|December 14, 2018
A Multi-Mode Bioactive Agent Isolated From <i>Ficus microcarpa</i> L. Fill. With Therapeutic Potential for Type 2 Diabetes MellitusNosheen Akhtar, Laila Jafri, Brian D Green, et al.
Frontiers in Pharmacology|July 2, 2019
Corrigendum: A Multi-Mode Bioactive Agent Isolated From <i>Ficus microcarpa</i> L. Fill. With Therapeutic Potential for Type 2 Diabetes MellitusNosheen Akhtar, Laila Jafri, Brian D Green, et al.
Pageof 12